Blog | Vanrx

Bring new drug products to market faster

October 15, 2018 - Blog, Featured

In a June 2018 interview with McKinsey & Company, Esteban Santos, executive vice president for operations at Amgen, described the current state of the biopharma market and the resulting need for companies to bring new drug products to market faster. This blog will explore how Vanrx’s aseptic processing machines can accelerate drug development, build facilities faster and respond faster to changing market conditions.

Manual aseptic processing needs to end

September 7, 2018 - Blog, cell therapy, Featured, Gene therapy

Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.